{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T02:47:13Z","timestamp":1769568433074,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"DOI":"10.7759\/cureus.102396","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:53:06Z","timestamp":1769521986000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis"],"prefix":"10.7759","author":[{"given":"Keidai","family":"Kumazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel CH","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024, 331:1480-91. 10.1001\/jama.2024.2315","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2012.03.007","article-title":"Systemic lupus erythematosus in children and adolescents","volume":"59","author":"Levy DM","year":"2012","unstructured":"Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am. 2012, 59:345-64. 10.1016\/j.pcl.2012.03.007","journal-title":"Pediatr Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis A","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, et al.. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019, 78:736-45. 10.1136\/annrheumdis-2019-215089","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.918","article-title":"SLE initially presenting with neuropsychiatric manifestations and seizure, case report","volume":"11","author":"Khormi AA","year":"2023","unstructured":"Khormi AA, Hijazi FT. SLE initially presenting with neuropsychiatric manifestations and seizure, case report. Immun Inflamm Dis. 2023, 11:e918. 10.1002\/iid3.918","journal-title":"Immun Inflamm Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008","volume":"49","author":"Fujimura Y","year":"2010","unstructured":"Fujimura Y, Matsumoto M. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Intern Med. 2010, 49:7-15. 10.2169\/internalmedicine.49.2706","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000359","article-title":"Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus","volume":"6","author":"Hirohata S","year":"2019","unstructured":"Hirohata S, Tanaka K. Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus. Lupus Sci Med. 2019, 6:e000359. 10.1136\/lupus-2019-000359","journal-title":"Lupus Sci Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2016.12.4.502","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in a patient with systemic lupus erythematosus","volume":"12","author":"Wu YY","year":"2016","unstructured":"Wu YY, Feng Y, Huang Y, Zhang JW. Anti-N-methyl-D-aspartate receptor encephalitis in a patient with systemic lupus erythematosus. J Clin Neurol. 2016, 12:502-4. 10.3988\/jcn.2016.12.4.502","journal-title":"J Clin Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.10.007","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","volume":"176","author":"Kayser MS","year":"2016","unstructured":"Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2016, 176:36-40. 10.1016\/j.schres.2014.10.007","journal-title":"Schizophr Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio LA","year":"2001","unstructured":"DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001, 7:1189-93. 10.1038\/nm1101-1189","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma Y","year":"2008","unstructured":"Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008, 58:1130-5. 10.1002\/art.23399","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer MJ","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, et al.. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013, 12:157-65. 10.1016\/S1474-4422(12)70310-1","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau J","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10:63-74. 10.1016\/S1474-4422(10)70253-2","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.113.045518","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment","volume":"39","author":"Barry H","year":"2015","unstructured":"Barry H, Byrne S, Barrett E, Murphy KC, Cotter DR. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bull. 2015, 39:19-23. 10.1192\/pb.bp.113.045518","journal-title":"BJPsych Bull"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019, 78:1151-9. 10.1136\/annrheumdis-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-024-09475-8","article-title":"Low C4A copy numbers and higher HERV gene insertion contributes to increased risk of SLE, with absence of association with disease phenotype and disease activity","volume":"72","author":"Mariaselvam CM","year":"2024","unstructured":"Mariaselvam CM, Seth G, Kavadichanda C, et al.. Low C4A copy numbers and higher HERV gene insertion contributes to increased risk of SLE, with absence of association with disease phenotype and disease activity. Immunol Res. 2024, 72:697-706. 10.1007\/s12026-024-09475-8","journal-title":"Immunol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456374-neuropsychiatric-systemic-lupus-erythematosus-diagnosed-following-treatment-initiated-for-acute-encephalitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:53:07Z","timestamp":1769521987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456374-neuropsychiatric-systemic-lupus-erythematosus-diagnosed-following-treatment-initiated-for-acute-encephalitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.102396","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}